Mae Zakhour

NPI 1427342294ActiveIndividual· Obstetrics & Gynecology, Gynecologic Oncology· Grand Rapids, MI

Obstetrics & Gynecology, Gynecologic Oncology in Grand Rapids, Michigan, trained at University of Texas Southwestern Medical School at Dallas (class of 2009). Their prescriptions cost Medicare Part D more than their services did: $105,364 for 297 claims, against $42,362 paid for services in 2024. Astrazeneca Pharmaceuticals LP was the largest of 2 companies reporting payments in 2025, $2,585 in all, mostly consulting fees.

Overview

NPI	1427342294
Status	Active
Entity type	Individual
Sole proprietor	No
NPI issued	Jun 8, 2011
Last updated in NPPES	Jul 11, 2022
Certified by provider	Jul 11, 2022

Specialties and licenses

Taxonomy	Code	License	State
Obstetrics & Gynecology, Gynecologic Oncology Primary	207VX0201X	A115768	CA

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Oct 9, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026	No match	—
New York OMIG · Nov 10, 2026	No match	—
Ohio Medicaid · Nov 10, 2026	No match	—
Pennsylvania Medicheck · Nov 10, 2026	No match	—
Washington HCA · Nov 10, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Gynecological Oncology (MI)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	77
Services billed	200 across 43 procedure codes
Paid by Medicare	$42,362

Part D prescriptions in 2024

Prescriptions (claims)	297 · 358 30-day fills
Patients	81
Total drug cost	$105,364
Generic share	91% of claims

Medicare sources and data years

Education and affiliations

Medical school	University of Texas Southwestern Medical School at Dallas
Graduation year	2009
Medicare specialty	Gynecological Oncology
Secondary specialties	Obstetrics/Gynecology
Telehealth	Offers telehealth